Drug
Ibuprofen
Ibuprofen: highest development phase Approved, developed by Abbott Laboratories, Boehringer Ingelheim, Orion Corporation and others. 6 trial records tracked on RxWires.
- Highest phase
- Approved
- Developer
- Abbott Laboratories, Boehringer Ingelheim, Orion Corporation
Trials
| Drug | Phase | Indication |
|---|---|---|
| IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE | Approved | |
| IBU | Approved | |
| Ibuprofen NCT01563289 | Phase 3 | Pain |
| Ibuprofen Tablets, 800 mg NCT00804440 | Phase 1 | Bioequivalency |
| Ibuprofen NCT02629354 | Phase 1 | Healthy |
| Ibuprofen Tablets, 800 mg NCT00803946 | Phase 1 | Bioequivalency |
Latest
No recent events.
Follow Ibuprofen on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.